F Weidinger

Author PubWeight™ 22.04‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Late prognostic value of flow-mediated dilation in the brachial artery of patients with chest pain. Am J Cardiol 2000 1.95
2 Systemic endothelial dysfunction is related to the extent and severity of coronary artery disease. Atherosclerosis 1997 1.57
3 Robotic totally endoscopic coronary artery bypass: program development and learning curve issues. J Thorac Cardiovasc Surg 2004 1.02
4 Effects of vitamin E on chronic and acute endothelial dysfunction in smokers. J Am Coll Cardiol 2000 0.94
5 Genetic augmentation of nitric oxide synthase increases the vascular generation of VEGF. Cardiovasc Res 2001 0.94
6 Arterial remodelling of native human coronary arteries in patients with unstable angina pectoris: a prospective intravascular ultrasound study. Heart 1999 0.93
7 Vascular endothelial growth factor (VEGF) plasma concentrations in coronary artery disease. Heart 2005 0.90
8 Impairment of endothelium-independent vasodilation in patients with hypercalcemia. Cardiovasc Res 1998 0.90
9 The frequency of prescription of P-glycoprotein-affecting drugs in atrial fibrillation. J Thromb Haemost 2010 0.87
10 Additional benefit of vitamin E supplementation to simvastatin therapy on vasoreactivity of the brachial artery of hypercholesterolemic men. J Am Coll Cardiol 1998 0.86
11 High-density lipoprotein cholesterol, C-reactive protein, and prevalence and severity of coronary artery disease in 5641 consecutive patients undergoing coronary angiography. Eur J Clin Invest 2008 0.86
12 Assessment of changes in vasomotor tone in vivo using intravascular ultrasound. J Pharmacol Toxicol Methods 1992 0.86
13 Coronary risk factors influence plaque morphology in patients with unstable angina. Coron Artery Dis 1999 0.86
14 Vascular endothelial growth factor synthesis in vascular smooth muscle cells is enhanced by 7-ketocholesterol and lysophosphatidylcholine independently of their effect on nitric oxide generation. Atherosclerosis 2001 0.84
15 [Dynamic obstruction of the left ventricular outflow tract by prosthesis dysfunction]. Z Kardiol 1995 0.82
16 Is oxidative stress causally linked to unstable angina pectoris? A study in 100 CAD patients and matched controls. Cardiovasc Res 1997 0.82
17 Intravascular ultrasound predictors of major adverse cardiac events in patients with unstable angina. Clin Cardiol 2000 0.81
18 [Heavy metal and trace element deviations. A comparison of idiopathic dilated cardiomyopathy and coronary heart disease]. Wien Med Wochenschr 1987 0.79
19 Role of beta-endorphins in silent myocardial ischemia. Am J Cardiol 1986 0.79
20 Blockade of endothelium-derived relaxing factor synthesis with NG-nitro-L-arginine methyl ester leads to enhanced venous reactivity in vivo. Eur J Pharmacol 1992 0.79
21 Short- and long-term outcomes of Wiktor stent implantation at low versus high pressures. Austrian Wiktor Stent Study Group. Am J Cardiol 1999 0.78
22 Increased intimal apoptosis in coronary atherosclerotic vessel segments lacking compensatory enlargement. J Am Coll Cardiol 2001 0.77
23 Calcium score as assessed by multi-slice computed tomography does not predict maximum plaque burden: an in vitro study. Heart 2004 0.77
24 Vascular endothelial growth factor: angiogenesis, atherogenesis or both? J Am Coll Cardiol 2001 0.77
25 Vascular endothelial growth factor (VEGF) in ankylosing spondylitis--a pilot study. Wien Med Wochenschr 2002 0.76
26 Intravascular ultrasound study in heart transplant recipients at proximal and distal branch points. Am J Cardiol 2001 0.75
27 Epoprostenol in patients with Raynaud's disease. Prostaglandins Leukot Essent Fatty Acids 1988 0.75
28 Potential life-threatening cardiac arrhythmias associated with a conventional hypocaloric diet. Int J Cardiol 1987 0.75
29 Altered reactivity of the inferior vena cava to noradrenaline and acetylcholine following the blockade of EDRF-biosynthesis with NG-nitro-L-arginine methyl ester. Clin Exp Pharmacol Physiol 1996 0.75
30 Venous tone in correlation to position in normal case and in patients with phlebothrombosis. Angiology 1970 0.75
31 [Heart transplantation: indication, selection criteria and patient management]. Wien Med Wochenschr 1990 0.75
32 Therapeutic efficiency of lipoprotein(a) reduction by low-density lipoprotein immunoapheresis. Metabolism 1998 0.75
33 Regression of coronary atherosclerosis and amelioration of renal function during LDL-immunoadsorption therapy in a renal transplant recipient. Wien Klin Wochenschr 1996 0.75
34 [R spike potentials in ergometric stress: patients with dilated cardiomyopathy in comparison to coronary heart disease]. Wien Klin Wochenschr 1986 0.75